Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 4
1990 1
1991 2
1992 3
1993 3
1994 4
1995 3
1996 3
1997 4
1998 5
1999 6
2000 8
2001 7
2002 10
2003 12
2004 6
2005 17
2006 13
2007 7
2008 1
2009 3
2010 6
2011 4
2012 6
2013 4
2014 2
2015 3
2016 5
2017 4
2018 8
2019 4
2020 4
2021 5
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.
Eyck BM, van der Wilk BJ, Lagarde SM, Wijnhoven BPL, Valkema R, Spaander MCW, Nuyttens JJME, van der Gaast A, van Lanschot JJB. Eyck BM, et al. Among authors: valkema r. Best Pract Res Clin Gastroenterol. 2018 Oct-Dec;36-37:37-44. doi: 10.1016/j.bpg.2018.11.007. Epub 2018 Nov 22. Best Pract Res Clin Gastroenterol. 2018. PMID: 30551855 Review.
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP.
Driessen J, Kersten MJ, Visser L, van den Berg A, Tonino SH, Zijlstra JM, Lugtenburg PJ, Morschhauser F, Hutchings M, Amorim S, Gastinne T, Nijland M, Zwezerijnen GJC, Boellaard R, de Vet HCW, Arens AIJ, Valkema R, Liu RDK, Drees EEE, de Jong D, Plattel WJ, Diepstra A; HOVON Lunenburg Lymphoma Phase I/II Consortium (LLPC). Driessen J, et al. Among authors: valkema r. Leukemia. 2022 Dec;36(12):2853-2862. doi: 10.1038/s41375-022-01717-8. Epub 2022 Oct 14. Leukemia. 2022. PMID: 36241696
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Forrer F, Valkema R, Kwekkeboom DJ, de Jong M, Krenning EP. Forrer F, et al. Among authors: valkema r. Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):111-29. doi: 10.1016/j.beem.2007.01.007. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17382268 Review.
Peptide-receptor radionuclide therapy for endocrine tumors.
van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. van Essen M, et al. Among authors: valkema r. Nat Rev Endocrinol. 2009 Jul;5(7):382-93. doi: 10.1038/nrendo.2009.105. Epub 2009 Jun 2. Nat Rev Endocrinol. 2009. PMID: 19488074 Review.
Peptide receptor radionuclide therapy.
Krenning EP, Kwekkeboom DJ, Valkema R, Pauwels S, Kvols LK, De Jong M. Krenning EP, et al. Among authors: valkema r. Ann N Y Acad Sci. 2004 Apr;1014:234-45. doi: 10.1196/annals.1294.026. Ann N Y Acad Sci. 2004. PMID: 15153440 Review.
Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.
van der Wilk BJ, Eyck BM, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB. van der Wilk BJ, et al. Among authors: valkema r. Dig Surg. 2019;36(6):462-469. doi: 10.1159/000493435. Epub 2018 Sep 18. Dig Surg. 2019. PMID: 30227434 Free PMC article. Review.
Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, van der Lely AJ, Krenning EP. de Herder WW, et al. Among authors: valkema r. J Endocrinol Invest. 2005;28(11 Suppl International):132-6. J Endocrinol Invest. 2005. PMID: 16625862 Review.
The use of bisphosphonates in the treatment of osteoporosis.
Papapoulos SE, Landman JO, Bijvoet OL, Löwik CW, Valkema R, Pauwels EK, Vermeij P. Papapoulos SE, et al. Among authors: valkema r. Bone. 1992;13 Suppl 1:S41-9. doi: 10.1016/s8756-3282(09)80009-4. Bone. 1992. PMID: 1581119 Review.
168 results